Uncategorized
Australia grants patent for Dropless Therapy formulations
The Australian Patent Office has issued Imprimis Pharmaceuticals its first patent covering Dropless Therapy formulations, the company announced in a press release.The patent covers “pharmaceutical compositions for intraocular administration comprising an antibacterial agent and an anti-inflammatory agent,” the release said, and it will expire March 27, 2034.